Following robust equity market performance in 2024, the first quarter of 2025 has been characterized by volatility. Despite this, earnings growth projections remain strong across a wider range of stocks, and market sentiment appears to have potentially reached an inflection point. Furthermore, the transformative impact of generative AI on health care and equity markets is poised to reshape the investment landscape in the coming years.

Join Lord Abbett investment leaders as they cover these key topics, and also discuss:

• The market’s historical underestimation of the growth potential of transformative technologies and why generative AI may be similarly underestimated.
• The phases of generative AI buildout and its significant contributions to health care, including drug discovery, diagnostics, and clinical productivity.